Your browser doesn't support javascript.
loading
Nonpegylated Liposomal Doxorubicin as a Component of R-CHOP Is an Effective and Safe Alternative to Conventional Doxorubicin in the Treatment of Patients With Diffuse Large B-Cell Lymphoma and Preexisting Cardiac Diseases.
Rohlfing, Sarah; Aurich, Matthias; Schöning, Tilman; Ho, Anthony D; Witzens-Harig, Mathias.
Afiliação
  • Rohlfing S; Department of Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany. Electronic address: sarah.rohlfing@med.uni-heidelberg.de.
  • Aurich M; Department of Cardiology, University Hospital of Heidelberg, Heidelberg, Germany.
  • Schöning T; Pharmacy, University Hospital of Heidelberg, Heidelberg, Germany.
  • Ho AD; Department of Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany.
  • Witzens-Harig M; Department of Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany.
Clin Lymphoma Myeloma Leuk ; 15(8): 458-63, 2015 Aug.
Article em En | MEDLINE | ID: mdl-25899891

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Doxorrubicina / Linfoma Difuso de Grandes Células B / Cardiopatias Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged80 Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Doxorrubicina / Linfoma Difuso de Grandes Células B / Cardiopatias Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged80 Idioma: En Ano de publicação: 2015 Tipo de documento: Article